Senior Vice President, Worldwide Commercial Portfolio Strategy
Bristol Myers Squibb
Cathleen Ahearn is senior vice president of Worldwide Commercial Portfolio Strategy at Bristol Myers Squibb (BMS) in Lawrenceville, New Jersey. She has 25 years of experience in the pharmaceutical industry and has led the worldwide commercial portfolio strategy organization at BMS since 2021.
After receiving her Bachelor of Arts degree in psychology at University of California, Los Angeles, Cathleen received her Master of Business Administration degree from the Fuqua School of Business at Duke University in Durham, North Carolina. She went on to rise through the ranks of the pharmaceutical industry in the areas of portfolio management, drug development and commercialization across multiple therapeutic areas. For more than 20 years, Cathleen focused on developing and launching therapies to treat cancer across tumor types and treatment settings.
Cathleen is a skilled communicator who has demonstrated an ability to inspire high levels of team engagement throughout her career. She is a champion of a patient-centric culture that focuses on growth, performance, and collaboration.